Cannabis Clinical Trials

Bod Australia has shown that CBD can be delivered into a patient’s bloodstream using its patented wafer during its phase one clinical trial. Cosmetics and natural medicines company Bod Australia (ASX: BDA) has achieved what it calls a “world-first” in the clinical trial of its proprietary phytocomplex cannabis extract ECs315, showing that cannabidiol (CBD) can […]

by

Photo Credit: Bloomberg – Workers inspect cannabis plants growing inside a shipping container grow pod at the Delta 9 Cannabis Inc. facility in Winnipeg, Manitoba, Canada, on Tuesday, Sept. 25, 2018. Delta 9 Cannabis will have a 3,200-square-foot store open when pot becomes legal on October 17. Photographer: Trevor Hagan/Bloomberg As cannabis sales become legal […]

by

Available now: Cannabis Professional, the authoritative e-mail newsletter tailored specifically for professionals in the rapidly evolving cannabis industry. Subscribe now. Younger drivers are more at risk of crashing a vehicle up to five hours after they consume cannabis, according to a new clinical trial at McGill University that researchers say underscores the need for Canadians […]

by

FRIDAY, Oct. 12, 2018 — Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients. Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments from clinical […]

by

Cowen analysts recently published an in-depth valuation of key players in the cannabis industry drawing from historical data and market trend. The valuation includes an outline of the potential market opportunity for the cannabis sector beyond legalization in Canada next week. Cowen’s Vivien Azer named four consumer verticals she expects the cannabis sector to touch.  1. Adult Use […]

by

FRIDAY, Oct. 12, 2018 (HealthDay News) — Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients. Drugs containing the major chemical compounds in cannabis are associated with a limited and mild reduction in muscle contractions, bladder dysfunction and pain, based on patient self-assessments […]

by

Interferons for MS: What You Need to Know By Dennis Thompson HealthDay Reporter FRIDAY, Oct. 12, 2018 (HealthDay News) — Medical products derived from marijuana might have a mild benefit in treating symptoms of multiple sclerosis, based on reports from patients. Drugs containing the major chemical compounds in cannabis are associated with a limited and […]

by